Research Article
The Role of Clinical and Instrumented Outcome Measures in Balance Control of Individuals with Multiple Sclerosis
Table 2
Test scores for the MS-F and MS-NF groups.
| Outcome measure | MS-F () | MS-NF () | P value |
| BBS | 46 ± 9.29 | 49.83 ± 7.38 | 0.44 | ABC scale (%) | 66.43 ± 20.08 | 65.10 ± 16.02 | 0.90 | Composite COG sway velocity (deg/s) | 1.41 ± 0.47 | 1.27 ± 0.54 | 0.64 | Composite RT (s) | 0.95 ± 0.33 | 1.10 ± 0.22 | 0.39 | Composite MVL (deg/s) | 2.84 ± 0.80 | 2.73 ± 0.56 | 0.81 | Composite EPE (%) | 52.80 ± 13.82 | 63.17 ± 16.84 | 0.30 | Composite MXE (%) | 74.80 ± 14.11 | 77.50 ± 16.79 | 0.78 | Composite DCL (%) | 67 ± 6.36 | 69 ± 11.62 | 0.74 | FSS | 4.31 ± 1.02 | 6.08 ± 0.71 | 0.006* | Protective sensation | Absent in 4 | Absent in 2 | 0.27 | Vibration | Absent in 1 | Present in all | 0.32 | BI | 19 ± 1.09 | 19.33 ± 0.81 | 0.60 |
|
|
Mean ± standard deviations are shown, *significant at P < 0.01.
|